US Stock MarketDetailed Quotes

Sensus Healthcare (SRTS)

Watchlist
  • 3.940
  • +0.010+0.25%
Close Apr 24 16:00 ET
  • 3.940
  • 0.0000.00%
Post 20:01 ET
64.86MMarket Cap-8.38P/E (TTM)

Sensus Healthcare (SRTS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-34.26%27.48M
-62.20%4.94M
-22.12%6.88M
-20.82%7.32M
-21.75%8.34M
71.31%41.81M
3.97%13.07M
126.76%8.84M
104.09%9.24M
212.33%10.66M
Operating revenue
-34.26%27.48M
-62.20%4.94M
-22.12%6.88M
-20.82%7.32M
-21.75%8.34M
71.31%41.81M
3.97%13.07M
126.76%8.84M
104.09%9.24M
212.33%10.66M
Cost of revenue
-10.13%15.62M
-48.96%3.04M
15.89%4.17M
15.62%4.41M
-0.27%3.99M
67.97%17.38M
25.84%5.96M
88.53%3.6M
100.00%3.82M
123.27%4M
Gross profit
-51.43%11.87M
-73.30%1.9M
-48.23%2.71M
-46.47%2.9M
-34.64%4.35M
73.76%24.43M
-9.26%7.11M
163.45%5.24M
107.06%5.42M
310.73%6.66M
Operating expense
35.70%22.17M
-6.23%5.05M
41.04%5.28M
40.83%4.85M
85.43%7M
13.15%16.34M
138.69%5.38M
-3.58%3.75M
-8.14%3.44M
-17.23%3.78M
Selling and administrative expenses
18.73%14.4M
-17.18%3.16M
20.16%3.46M
31.07%3.38M
54.23%4.39M
12.64%12.13M
142.17%3.82M
2.89%2.88M
-11.94%2.58M
-17.73%2.85M
-Selling and marketing expense
31.04%6.52M
-0.14%1.4M
18.11%1.55M
39.46%1.39M
72.13%2.19M
-11.23%4.98M
124.48%1.4M
1.47%1.31M
-37.55%996K
-39.49%1.27M
-General and administrative expense
10.16%7.87M
-27.07%1.76M
21.87%1.92M
25.78%1.99M
39.84%2.21M
38.62%7.15M
153.78%2.42M
4.10%1.57M
18.81%1.58M
15.76%1.58M
Research and development costs
84.49%7.78M
20.56%1.88M
110.78%1.82M
69.86%1.47M
181.43%2.61M
14.63%4.22M
130.58%1.56M
-20.31%863K
5.35%866K
-15.66%926K
Operating profit
-227.40%-10.31M
-282.39%-3.15M
-271.84%-2.57M
-198.03%-1.94M
-191.65%-2.65M
2,217.80%8.09M
-69.05%1.73M
178.89%1.5M
275.87%1.98M
198.23%2.89M
Net non-operating interest income expense
-26.72%683K
-32.61%155K
-42.65%160K
-12.44%183K
-14.02%184K
-6.05%932K
0.88%230K
0.72%279K
-14.69%209K
-11.93%214K
Non-operating interest income
-26.72%683K
-32.61%155K
-42.65%160K
-12.44%183K
-14.02%184K
-6.05%932K
0.88%230K
0.72%279K
-14.69%209K
-11.93%214K
Other net income (expense)
Special income (charges)
----
----
----
----
----
--0
--0
--0
----
----
-Gain on sale of property,plant,equipment
----
----
----
----
----
--0
--0
--0
----
----
Income before tax
-206.67%-9.62M
-253.02%-2.99M
-235.79%-2.41M
-180.33%-1.76M
-179.39%-2.46M
1,283.74%9.02M
-66.30%1.96M
212.56%1.77M
348.41%2.19M
215.02%3.1M
Income tax
-180.21%-1.91M
-57.56%174K
-362.25%-1.47M
-224.87%-723K
-86.70%110K
1,322.16%2.38M
-74.29%410K
547.20%559K
215.34%579K
203.12%827K
Net income
-216.13%-7.72M
-304.85%-3.17M
-177.61%-943K
-164.33%-1.04M
-213.10%-2.57M
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
Net income continuous Operations
-216.13%-7.72M
-304.85%-3.17M
-177.61%-943K
-164.33%-1.04M
-213.10%-2.57M
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
Minority interest income
Net income attributable to the parent company
-216.13%-7.72M
-304.85%-3.17M
-177.61%-943K
-164.33%-1.04M
-213.10%-2.57M
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-216.13%-7.72M
-304.85%-3.17M
-177.61%-943K
-164.33%-1.04M
-213.10%-2.57M
1,270.52%6.65M
-63.28%1.55M
183.74%1.22M
524.21%1.61M
220.06%2.27M
Basic earnings per share
-214.63%-0.47
-311.11%-0.19
-185.71%-0.06
-160.00%-0.06
-214.29%-0.16
1,266.67%0.41
-65.38%0.09
177.78%0.07
600.00%0.1
216.67%0.14
Diluted earnings per share
-214.63%-0.47
-311.11%-0.19
-185.71%-0.06
-160.00%-0.06
-214.29%-0.16
1,266.67%0.41
-65.38%0.09
177.78%0.07
600.00%0.1
216.67%0.14
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -34.26%27.48M-62.20%4.94M-22.12%6.88M-20.82%7.32M-21.75%8.34M71.31%41.81M3.97%13.07M126.76%8.84M104.09%9.24M212.33%10.66M
Operating revenue -34.26%27.48M-62.20%4.94M-22.12%6.88M-20.82%7.32M-21.75%8.34M71.31%41.81M3.97%13.07M126.76%8.84M104.09%9.24M212.33%10.66M
Cost of revenue -10.13%15.62M-48.96%3.04M15.89%4.17M15.62%4.41M-0.27%3.99M67.97%17.38M25.84%5.96M88.53%3.6M100.00%3.82M123.27%4M
Gross profit -51.43%11.87M-73.30%1.9M-48.23%2.71M-46.47%2.9M-34.64%4.35M73.76%24.43M-9.26%7.11M163.45%5.24M107.06%5.42M310.73%6.66M
Operating expense 35.70%22.17M-6.23%5.05M41.04%5.28M40.83%4.85M85.43%7M13.15%16.34M138.69%5.38M-3.58%3.75M-8.14%3.44M-17.23%3.78M
Selling and administrative expenses 18.73%14.4M-17.18%3.16M20.16%3.46M31.07%3.38M54.23%4.39M12.64%12.13M142.17%3.82M2.89%2.88M-11.94%2.58M-17.73%2.85M
-Selling and marketing expense 31.04%6.52M-0.14%1.4M18.11%1.55M39.46%1.39M72.13%2.19M-11.23%4.98M124.48%1.4M1.47%1.31M-37.55%996K-39.49%1.27M
-General and administrative expense 10.16%7.87M-27.07%1.76M21.87%1.92M25.78%1.99M39.84%2.21M38.62%7.15M153.78%2.42M4.10%1.57M18.81%1.58M15.76%1.58M
Research and development costs 84.49%7.78M20.56%1.88M110.78%1.82M69.86%1.47M181.43%2.61M14.63%4.22M130.58%1.56M-20.31%863K5.35%866K-15.66%926K
Operating profit -227.40%-10.31M-282.39%-3.15M-271.84%-2.57M-198.03%-1.94M-191.65%-2.65M2,217.80%8.09M-69.05%1.73M178.89%1.5M275.87%1.98M198.23%2.89M
Net non-operating interest income expense -26.72%683K-32.61%155K-42.65%160K-12.44%183K-14.02%184K-6.05%932K0.88%230K0.72%279K-14.69%209K-11.93%214K
Non-operating interest income -26.72%683K-32.61%155K-42.65%160K-12.44%183K-14.02%184K-6.05%932K0.88%230K0.72%279K-14.69%209K-11.93%214K
Other net income (expense)
Special income (charges) ----------------------0--0--0--------
-Gain on sale of property,plant,equipment ----------------------0--0--0--------
Income before tax -206.67%-9.62M-253.02%-2.99M-235.79%-2.41M-180.33%-1.76M-179.39%-2.46M1,283.74%9.02M-66.30%1.96M212.56%1.77M348.41%2.19M215.02%3.1M
Income tax -180.21%-1.91M-57.56%174K-362.25%-1.47M-224.87%-723K-86.70%110K1,322.16%2.38M-74.29%410K547.20%559K215.34%579K203.12%827K
Net income -216.13%-7.72M-304.85%-3.17M-177.61%-943K-164.33%-1.04M-213.10%-2.57M1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M
Net income continuous Operations -216.13%-7.72M-304.85%-3.17M-177.61%-943K-164.33%-1.04M-213.10%-2.57M1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M
Minority interest income
Net income attributable to the parent company -216.13%-7.72M-304.85%-3.17M-177.61%-943K-164.33%-1.04M-213.10%-2.57M1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -216.13%-7.72M-304.85%-3.17M-177.61%-943K-164.33%-1.04M-213.10%-2.57M1,270.52%6.65M-63.28%1.55M183.74%1.22M524.21%1.61M220.06%2.27M
Basic earnings per share -214.63%-0.47-311.11%-0.19-185.71%-0.06-160.00%-0.06-214.29%-0.161,266.67%0.41-65.38%0.09177.78%0.07600.00%0.1216.67%0.14
Diluted earnings per share -214.63%-0.47-311.11%-0.19-185.71%-0.06-160.00%-0.06-214.29%-0.161,266.67%0.41-65.38%0.09177.78%0.07600.00%0.1216.67%0.14
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More